about
Recognition of human oncogenic viruses by host pattern-recognition receptorsRole of innate immunity in the development of hepatocellular carcinomaHCV-Mediated Apoptosis of Hepatocytes in Culture and Viral PathogenesisIdentification and genotyping of feline infectious peritonitis-associated single nucleotide polymorphisms in the feline interferon-γ geneAn interferon response gene signature is associated with the therapeutic response of hepatitis C patientsUtility, limitations, and future of non-human primates for dengue research and vaccine developmentStrong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 geneImpairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytesHepatitis C Virus. Strategies to Evade Antiviral ResponsesDynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus InfectionIFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research.Landscape of post-transcriptional gene regulation during hepatitis C virus infectionIFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells.Replication priority of hepatitis C virus genotype 2a in a Chinese cohort.Recent advances in the anti-HCV mechanisms of interferon.Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver.Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C.Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antiviralsIdentification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitroIndividualization of chronic hepatitis C treatment according to the host characteristics.New concepts of sofosbuvir-based treatment regimens in patients with hepatitis C.Hepatitis C, innate immunity and alcohol: friends or foes?Insights into antiviral innate immunity revealed by studying hepatitis C virus.Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.Inflammasome activation and function in liver disease.Immune therapy for hepatocellular carcinoma.Progress in the development of vaccines for hepatitis C virus infection.SOCS1 is an inducible negative regulator of IFN lambda induced gene expression in vivo.The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.Endogenously produced TNF-α contributes to the expression of CXCL10/IP-10 in IFN-λ3-activated plasmacytoid dendritic cells.Hepatitis C may enhance key amplifiers of psoriasis.MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response.Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
P2860
Q27010116-28078670-6E7C-47BF-8006-2027AB9E6BA5Q27024780-DB01679B-E18D-4249-9CCA-245D03263E9AQ27469084-254521E8-6BA0-4BC4-A843-2AA01D6B316AQ33700581-8CE8DE24-63F7-4C98-A370-4087C4C5DCDBQ34027569-FED68540-A69D-4AF9-B353-0A7E25A2DD00Q34238916-F69F2533-7B43-45B9-8C6D-B0153E6C3606Q34449537-0B8F8626-E635-4A7A-891C-ECBE0DF1285FQ34506224-46FFD017-692D-4129-9D5E-6D7E96754437Q34750577-28F287E2-7280-475D-9D43-D4A88EBA463EQ35199204-2080DDF4-DD49-45A1-91AC-9E3EE268042DQ35590991-9458CA0D-2F01-421D-8200-48BC165FB483Q35604054-BFA773B5-CE0D-40B1-A2C1-A53C179D724FQ35641517-6EFEE001-82CA-4159-A7A5-55269AE45BA0Q35675878-6E4B4419-980D-4638-A0E6-1C44BA7F8385Q35756038-AC9BCC81-DC8B-4179-A211-22C1BE9925E1Q35921378-D3482985-8E7C-4E20-8020-786E3696C4EBQ36237550-A204AC79-0401-4411-AA3D-9C68D4251DEFQ36237584-6775D610-7066-44ED-8BD5-0F41C4AAF02BQ36255920-3F7B5643-ADEB-4ABB-8C64-2FF013DB103CQ36675098-40F1163D-5814-4ABA-9911-8FD6FF03E227Q37095314-34F7ABE2-2EE2-4BDB-88CB-F6335BAEB58EQ37188844-59E75195-2B7D-4D7F-9CC6-881F58353A15Q37189852-DFA4895B-747F-4F12-B229-F39E61D15385Q37336496-F8B88F9B-7232-4B06-AA32-851D2ADA7A51Q37547206-7F728595-D621-4238-806C-9B19C7E5EE2EQ37547599-3D0DA124-59D5-441F-AB56-D414119804D3Q37654502-84A13918-2AE2-4182-9874-8782C5BCAD2DQ38164242-C40D1605-32BC-46E5-B1FF-EDB7C7A350E7Q38349031-2BB52C30-040D-4316-8954-6BC6DCC1E91AQ38394763-DD1F0893-0F36-4BFB-9487-615BE55C7660Q38482765-BAA542B0-98B9-41DE-A22C-CE5BB25B048CQ38521274-0457EC52-EA14-456D-95E5-29B1ABC81F79Q38552117-3754C0E4-051F-4204-A5AD-16AAA7171083Q38635596-4F49F09A-2AB7-4FE3-B83E-333B31D563F1Q40044687-2AA7D67E-915C-47B2-BBFE-B0470FB458F7Q40337789-CA587BEE-047A-4840-9C4A-A9CE45E22360Q40527049-9A1DB2AC-2189-4BC3-8ED9-6CCA78257772Q40672891-F1D5604C-89E4-4AB0-89AF-BE686BE7A848Q40691086-507DF704-5CC1-4503-A6E0-C6244FAA3363Q40982052-33FD62C8-A00D-4219-A8C7-B30734276F72
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Innate immunity and HCV.
@en
type
label
Innate immunity and HCV.
@en
prefLabel
Innate immunity and HCV.
@en
P1476
Innate immunity and HCV.
@en
P304
P356
10.1016/J.JHEP.2012.10.005
P577
2012-10-11T00:00:00Z